Integrated Filing — IndAS


General information about company

Scrip Code 500596
NSE Symbol HINDUNILVR
MSEI Symbol NOTLISTED
ISIN INE030A01027
Name of company Hindustan Unilever Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 24-Apr-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 24-Mar-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 24-Apr-2025   08:45:00
End date and time of board meeting 24-Apr-2025   10:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 156700000000 631210000000
Other income 3090000000 10170000000
Total income 159790000000 641380000000
2 Expenses
(a) Cost of materials consumed 48300000000 194580000000
(b) Purchases of stock-in-trade 28020000000 112730000000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -90000000 -1530000000
(d) Employee benefit expense 8560000000 30770000000
(e) Finance costs 800000000 3950000000
(f) Depreciation, depletion and amortisation expense 3470000000 13550000000
(f) Other Expenses
1 Advertising and promotion 15100000000 61990000000
2 Others 20620000000 84160000000
Total other expenses 35720000000 146150000000
Total expenses 124780000000 500200000000
3 Total profit before exceptional items and tax 35010000000 141180000000
4 Exceptional items -1380000000 3050000000
5 Total profit before tax 33630000000 144230000000
6 Tax expense
7 Current tax 8490000000 36200000000
8 Deferred tax 380000000 1240000000
9 Total tax expenses 8870000000 37440000000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 24760000000 106790000000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method -10000000 -80000000
16 Total profit (loss) for period 24750000000 106710000000
17 Other comprehensive income net of taxes -220000000 -190000000
18 Total Comprehensive Income for the period 24530000000 106520000000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 24640000000 106490000000
Total profit or loss, attributable to non-controlling interests 110000000 110000000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 24420000000 106300000000
Total comprehensive income for the period attributable to owners of parent non-controlling interests 110000000 220000000
21 Details of equity share capital
Paid-up equity share capital 2350000000 2350000000
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 491670000000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 10.48 45.32
Diluted earnings (loss) per share from continuing operations 10.48 45.32
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 10.48 45.32
Diluted earnings (loss) per share from continuing and discontinued operations 10.48 45.32
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 86250000000
Capital work-in-progress 10090000000
Investment property 0
Goodwill 174660000000
Other intangible assets 282440000000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 570000000
Non-current financial assets
Non-current investments 20000000
Trade receivables, non-current 0
Loans, non-current 870000000
Other non-current financial assets 7630000000
Total non-current financial assets 8520000000
Deferred tax assets (net) 170000000
Other non-current assets 15590000000
Total non-current assets 578290000000
2 Current assets
Inventories 44150000000
Current financial asset
Current investments 37510000000
Trade receivables, current 38190000000
Cash and cash equivalents 60710000000
Bank balance other than cash and cash equivalents 14830000000
Loans, current 460000000
Other current financial assets 14880000000
Total current financial assets 166580000000
Current tax assets (net) 0
Other current assets 9550000000
Total current assets 220280000000
3 Non-current assets classified as held for sale 230000000
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 798800000000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 2350000000
Other equity 491670000000
Total equity attributable to owners of parent 494020000000
Non controlling interest 2070000000
Total equity 496090000000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 19230000000
Total non-current financial liabilities 19230000000
Provisions, non-current 15280000000
Deferred tax liabilities (net) 66850000000
Deferred government grants, Non-current 0
Other non-current liabilities 35980000000
Total non-current liabilities 137340000000
Current liabilities
Current financial liabilities
Borrowings, current 10000000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 2630000000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 110520000000
Total Trade payable 113150000000
Other current financial liabilities 16840000000
Total current financial liabilities 130000000000
Other current liabilities 9590000000
Provisions, current 6750000000
Current tax liabilities (Net) 19030000000
Deferred government grants, Current 0
Total current liabilities 165370000000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 302710000000
Total equity and liabilites 798800000000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Home Care 58150000000 229580000000
2 Beauty & Wellbeing 32650000000 135230000000
3 Personal Care 21260000000 91660000000
4 Foods 38960000000 152940000000
5 Others (includes Exports, Consignment, etc.) 5680000000 21800000000
Total Segment Revenue 156700000000 631210000000
Less: Inter segment revenue
Revenue from operations 156700000000 631210000000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Home Care 10930000000 44290000000
2 Beauty & Wellbeing 10460000000 41880000000
3 Personal Care 3980000000 16310000000
4 Foods 6270000000 28080000000
5 Others (includes Exports, Consignment, etc.) 1080000000 4400000000
Total Profit before tax 32720000000 134960000000
i. Finance cost 800000000 800000000
ii. Other Unallocable Expenditure net off Unallocable income -1700000000 -1700000000
Profit before tax 33620000000 144150000000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Home Care 55730000000 55730000000
2 Beauty & Wellbeing 43910000000 43910000000
3 Personal Care 36920000000 36920000000
4 Foods 515710000000 515710000000
5 Others (includes Exports, Consignment, etc.) 11220000000 11220000000
Total Segment Asset 663490000000 663490000000
Un-allocable Assets 135310000000 135310000000
Net Segment Asset 798800000000 798800000000
4 Segment Liabilities
Segment Liabilities
1 Home Care 52570000000 52570000000
2 Beauty & Wellbeing 42520000000 42520000000
3 Personal Care 26910000000 26910000000
4 Foods 37300000000 37300000000
5 Others (includes Exports, Consignment, etc.) 4730000000 4730000000
Total Segment Liabilities 164030000000 164030000000
Un-allocable Liabilities 138680000000 138680000000
Net Segment Liabilities 302710000000 302710000000
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements of the net defined benefit plans -220000000 -220000000
Total Amount of items that will not be reclassified to profit and loss -220000000 -220000000
2 Income tax relating to items that will not be reclassified to profit or loss -50000000 -50000000
3 Amount of items that will be reclassified to profit and loss
1 Fair value of debt instruments through other comprehensive income 0 0
2 Fair value of cash flow hedges through other comprehensive income -50000000 -20000000
Total Amount of items that will be reclassified to profit and loss -50000000 -20000000
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -220000000 -190000000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 144230000000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 3720000000
Adjustments for decrease (increase) in inventories -5840000000
Adjustments for decrease (increase) in trade receivables, current -8460000000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -2420000000
Adjustments for decrease (increase) in other non-current assets -870000000
Adjustments for other financial assets, non-current -30000000
Adjustments for other financial assets, current -1870000000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 8330000000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 1520000000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 13630000000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 2450000000
Adjustments for provisions, non-current -1730000000
Adjustments for other financial liabilities, current 2120000000
Adjustments for other financial liabilities, non-current -1110000000
Adjustments for unrealised foreign exchange losses gains 40000000
Adjustments for dividend income 0
Adjustments for interest income 7550000000
Adjustments for share-based payments 110000000
Adjustments for fair value losses (gains) -2560000000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow -5950000000
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 3780000000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -2690000000
Net cash flows from (used in) operations 141540000000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 22680000000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 118860000000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 130000000
Purchase of property, plant and equipment 12540000000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets -210000000
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 8350000000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 69000000000
Net cash flows from (used in) investing activities 64730000000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 0
Payments of lease liabilities 4980000000
Dividends paid 124730000000
Interest paid 1300000000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -131010000000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 52580000000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 52580000000
Cash and cash equivalents cash flow statement at beginning of period 8120000000
Cash and cash equivalents cash flow statement at end of period 60700000000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/s. Walker Chandiok & Co. LLP Yes 31-May-2025


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date